| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |